Outcome of Down Syndrome Screening Using Quadruple Test at Phatthalung Hospital

Authors

  • Aurasiri Siriwipat Phatthalung Hospital

Keywords:

Quadruple Test, Down syndrome screening, Sensitivity, False positive rate

Abstract

Objective: To determine the prevalence of pregnant women with high-risk for fetal Down syndrome using Quadruple test and evaluate the sensitivity and false positive rate of Quadruple test at Phatthalung hospital.

Materials and Methods: Medical records of 1,021 pregnant women who accepted the second trimester Quadruple test for fetal Down syndrome during October 1st 2021- December 31st 2022 at Phatthalung hospital were retrospectively reviewed. Amniocentesis was offered to women who were classified as high risk for fetal Down syndrome from Quadruple Test. Down syndrome screening outcomes, sensitivity and false positive rate were evaluated.

Results: From 1,021 cases of pregnant women who had enrolled the Quadruple test for fetal Down syndrome screening in the second trimester, 98 cases (9.6%) had been found to have high risk for fetal Down syndrome. Chromosome studies from amniocentesis in high-risk cases showed 7 cases of fetal Down syndrome (4 cases of 47, XX+21 and 3 cases of 47, XY+21). All the pregnant women with prenatal diagnosis of fetal Down syndrome decided to terminate their pregnancy. The sensitivity of Quadruple test for Down syndrome was 87.5% with an 8.98% false positive rate.

Conclusion: The Quadruple test is effective for the second trimester Down syndrome screening. Pregnant women with high-risk for fetal Down syndrome were prevalent at 9.6%   with 87.5% of sensitivity and 8.98% of false positive rate.

References

Sherman SL, Allen EG, Bean LH, Freeman SB. Epidemiology of Down syndrome. Ment Retard Dev Disabil Res Rev. 2007;13(3): 221–7. doi: 10.1002/mrdd.20157.

Whooten R, Schmitt J, Schwartz A. Endocrine manifestations of Down syndrome: Current Opinion in Endocrinology & Diabetes and Obesity. 2018;25(1):61–6.

Bull MJ. Down Syndrome. N Engl J Med. 2020;382(24):2344–52.

คณะกรรมการจัดทำคู่มือการตรวจทางห้องปฏิบัติการกลุ่มอาการดาวน์ในหญิงตั้งครรภ์. คู่มือการตรวจทางห้องปฏิบัติการกลุ่มอาการดาวน์ในหญิงตั้งครรภ์. นนทบุรี:พรีเมียร์; 2562.

Geelhoed EA, Bebbington A, Bower C, Deshpande A, Leonard H. Direct Health Care Costs of Children and Adolescents with Down Syndrome. The Journal of Pediatrics. 2011;159:541–5.

Hook EB. Rates of chromosome abnormalities at different maternal ages. Obstet Gynecol. 1981; 58(3):282-5.

American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics, Committee on Genetics, Society for Maternal-Fetal Medicine. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226. Obstet Gynecol. 2020;136(4):e48–69.

Malone FD, Comstock CH, Dugoff L, Wolfe HM, Hackshaw AK, Lambert-Messerlian G. First-Trimester or Second-Trimester Screening, or Both, for Down’s Syndrome. N Engl J Med. 2005;2001-11.

Canick J. Prenatal screening for trisomy 21: recent advances and guidelines. Clin Chem Lab Med. 2012;50. doi:10.1515/cclm.2011.671.

Wald NJ, Rodeck C, Hackshaw AK, Rudnicka A. SURUSS in Perspective. Semin Perinatol. 2005;29:225–35.

Shaw SWS, Chen C-P, Cheng P-J. From Down syndrome screening to noninvasive prenatal testing: 20 years’ experience in Taiwan. Taiwan J Obstet Gynecol. 2013;52: 470–4.

Gil MM, Accurti V, Santacruz B, Plana MN, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2017;50:302–14.

Cunningham FG, Leveno KJ, Dashe JS, Hoffman BL, Spong CY, Casey BM. Williams Obstetrics. 26th ed. New York:McGraw Hill; 2022.

Salomon LJ, Sotiriadis A, Wulff CB, Odibo A, Akolekar R. Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis. Ultrasound Obstet Gynecol. 2019; 54:442–51.

Somsri S. Down syndrome screening outcomes in advanced maternal pregnant women at Roied hospital. Srinagarind Med J. 2021;35:513-21.

ธารางรัตน์ หาญประเสริฐพงษ์. เวชปฏิบัติผู้ป่วยนอกทางสูติศาสตร์. กรุงเทพมหานคร: สหมิตรการพิมพ์; 2560.

Yazdani S, Rouholahnejad R, Asnafi N, Sharbatdaran M, Zakershob M, Bouzari Z. Correlation of pregnancy outcome with quadruple screening test at second trimester. Med J Islam Repub Iran. 2015;29:281-6.

Downloads

Published

2023-06-28

How to Cite

Siriwipat, A. (2023). Outcome of Down Syndrome Screening Using Quadruple Test at Phatthalung Hospital. Region 11 Medical Journal, 37(2), 34–46. Retrieved from https://he02.tci-thaijo.org/index.php/Reg11MedJ/article/view/259857

Issue

Section

Original articles